Archive

29 Jul

Conference Home II

by

in

by

in

ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient enrolled in the Clinical Trial for Opioid Sparing in Participants with Radiculopathic Pain.
ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)
ANANDA Scientific’s Liquid Structure™ Cannabidiol (CBD) to be clinically evaluated for Opioid Use Disorder.
ANANDA Scientific and the David Geffen School of Medicine UCLA Announce a Clinical Trial Utilizing Liquid StructureTM Cannabidiol (CBD) for the Treatment of Opioid Use Disorder (OUD).
ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial Evaluating Liquid Structure™ Cannabidiol (CBD) for Treatment of Post-Traumatic Stress Disorder (PTSD)

Ananda Scientific is strongly positioned to bring cannabinoid-based therapeutics to patients who need it most. Ou… https://t.co/21qoxK09gO

2 months ago
We are pleased to announce that the first patient has been recruited in the FDA approved Clinical Trial evaluating… https://t.co/yZKZnFB21b

4 months ago
Ananda Scientific’s Liquid Structure™ Technology is a powerful delivery technology that makes Cannabinoids water so… https://t.co/6vc48ZL21q

5 months ago